Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials [Clinical Sciences]
Conclusions—
Reducing the OTT has robust beneficial effects for acute stroke patients. Prehospital tissue-type plasminogen activator treatment without brain imaging may become conceivable under several preconditions, including a point-of-care test with >75% to 80% sensitivity to detect intracerebral hemorrhage and a time gain of >32 to 40 minutes. Ethical implications remain to be addressed.
Source: Stroke - Category: Neurology Authors: Lorenz, M. W., Lauer, A., Foerch, C. Tags: Acute Cerebral Infarction, Emergency treatment of Stroke, Thrombolysis Clinical Sciences Source Type: research
More News: Brain | Clinical Trials | CT Scan | Emergency Medicine | Hemorrhagic Stroke | Ischemic Stroke | Medical Ethics | Neurology | PET Scan | Stroke